Search research articles
Contact Us
Filters
Showing results (331-340 of 341) with videos related to
Page
of 35
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
May 2, 2025
Discovery of TNG-6132, a potent, selective, and orally bioavailable USP1 inhibitor
Scott Throner, Tianshu Feng, Jannik N Andersen, et al.
Elife
|
September 14, 2017
Biochemical adaptations of the retina and retinal pigment epithelium support a metabolic ecosystem in the vertebrate eye
Mark A Kanow, Michelle M Giarmarco, Connor Sr Jankowski, et al.
Molecular Cancer Therapeutics
|
May 6, 2025
CRISPR screens identify POLB as a synthetic lethal enhancer of PARP inhibition exclusively in BRCA-mutated tumors
Katherine Lazarides, Justin L Engel, Michele Meseonznik, et al.
Molecular & Cellular Proteomics : MCP
|
March 16, 2017
Molecular Details Underlying Dynamic Structures and Regulation of the Human 26S Proteasome
Xiaorong Wang, Peter Cimermancic, Clinton Yu, et al.
JCO Clinical Cancer Informatics
|
December 2, 2025
Development of a Dynamic Counterfactual Risk Stratification Strategy for Newly Diagnosed Patients With AML Treated With Venetoclax and Azacitidine
Nazmul Islam, Justin L Dale, Jamie S Reuben, et al.
Molecular Cancer Therapeutics
|
October 13, 2022
Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer
Antoine Simoneau, Justin L Engel, Madhavi Bandi, et al.
Cancer Research
|
September 7, 2022
VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient Glioblastoma
Julie A Shields, Samuel R Meier, Madhavi Bandi, et al.
American Journal of Human Genetics
|
December 12, 2018
Aberrant Inclusion of a Poison Exon Causes Dravet Syndrome and Related SCN1A-Associated Genetic Epilepsies
Gemma L Carvill, Krysta L Engel, Aishwarya Ramamurthy, et al.
Genome Medicine
|
May 31, 2017
Genomic diagnosis for children with intellectual disability and/or developmental delay
Kevin M Bowling, Michelle L Thompson, Michelle D Amaral, et al.
Human Genetics
|
May 10, 2018
De novo mutations in MED13, a component of the Mediator complex, are associated with a novel neurodevelopmental disorder
Lot Snijders Blok, Susan M Hiatt, Kevin M Bowling, et al.
Page
of 35
Search research articles
Search
Showing results (331-340 of 341) with videos related to
Sort By:
Page
of 35
Bioorganic & Medicinal Chemistry Letters
|
May 2, 2025
Discovery of TNG-6132, a potent, selective, and orally bioavailable USP1 inhibitor
Scott Throner, Tianshu Feng, Jannik N Andersen, et al.
Elife
|
September 14, 2017
Biochemical adaptations of the retina and retinal pigment epithelium support a metabolic ecosystem in the vertebrate eye
Mark A Kanow, Michelle M Giarmarco, Connor Sr Jankowski, et al.
Molecular Cancer Therapeutics
|
May 6, 2025
CRISPR screens identify POLB as a synthetic lethal enhancer of PARP inhibition exclusively in BRCA-mutated tumors
Katherine Lazarides, Justin L Engel, Michele Meseonznik, et al.
Molecular & Cellular Proteomics : MCP
|
March 16, 2017
Molecular Details Underlying Dynamic Structures and Regulation of the Human 26S Proteasome
Xiaorong Wang, Peter Cimermancic, Clinton Yu, et al.
JCO Clinical Cancer Informatics
|
December 2, 2025
Development of a Dynamic Counterfactual Risk Stratification Strategy for Newly Diagnosed Patients With AML Treated With Venetoclax and Azacitidine
Nazmul Islam, Justin L Dale, Jamie S Reuben, et al.
Molecular Cancer Therapeutics
|
October 13, 2022
Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer
Antoine Simoneau, Justin L Engel, Madhavi Bandi, et al.
Cancer Research
|
September 7, 2022
VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient Glioblastoma
Julie A Shields, Samuel R Meier, Madhavi Bandi, et al.
American Journal of Human Genetics
|
December 12, 2018
Aberrant Inclusion of a Poison Exon Causes Dravet Syndrome and Related SCN1A-Associated Genetic Epilepsies
Gemma L Carvill, Krysta L Engel, Aishwarya Ramamurthy, et al.
Genome Medicine
|
May 31, 2017
Genomic diagnosis for children with intellectual disability and/or developmental delay
Kevin M Bowling, Michelle L Thompson, Michelle D Amaral, et al.
Human Genetics
|
May 10, 2018
De novo mutations in MED13, a component of the Mediator complex, are associated with a novel neurodevelopmental disorder
Lot Snijders Blok, Susan M Hiatt, Kevin M Bowling, et al.
Page
of 35